Apr 9 2007, 8:30 AM EST
News source: Business Wire
According to a recent study published by IMV Medical Information Division, patients made an estimated 23.2 million radiation therapy or related visits in the US, including 19.0 million treatment visits and 4.2 million allied visits in 2006. The top three cancer site types include breast, prostate and lung cancer, which account for 21%, 20% and 12%, respectively, of all cancer site types treated using radiation therapy.
"While the number of patients treated with radiation therapy every year is relatively stable, the technological sophistication of radiation oncology departments is continuing to advance. Digital imaging has become integrated into treatment planning and to guide tumor treatment real-time," observed Lorna Young, Senior Director, Market Research. "While in 2004, 15% of the radiation oncology sites provided Image Guided Radiotherapy (IGRT) in their department, over one-third of the sites do so now, using either a dedicated IGRT imaging device or electronic portal imaging. Ultrasound, x-ray and CT are the primary imaging modalities used in IGRT."
IMV's 2006 Radiation Oncology Market Summary Report describes trends in the adoption of therapeutic techniques, equipment and radioactive agents. Equipment types covered include linear accelerators, CT and PET/CT simulators, treatment planning systems, IGRT, record and verify / information management systems, remote afterloader brachytherapy and dedicated radiosurgery. Other technologies covered include IMRT, inverse planning, conformal radiotherapy, intraoperative radiation therapy (IORT), stereotactic radiosurgery and prostate seed therapy. Highlights include:
-- 90% of the radiation therapy sites use networks for sharing images used in treatment planning.
-- CT simulators comprised over 80% of the simulators installed in 2006.
-- Sites having budgets of $1.5+ million have increased from 15% of 2003 capital budgets to 33% of 2007 budgets.
-- 85% of the sites indicated that they have "record and verify / information management" systems installed.
The data source for this report is IMV's 2006/07 Radiation Oncology Census Database, which provides comprehensive profiles of radiation oncology sites in the United States. The database can be licensed by qualified subscribers and includes contact and site-specific information. Applications of the database include market analysis, market development, target marketing, lead generation, installed base marketing programs, sales territory deployment and competitive analysis.
For more information about IMV's Radiation Oncology Census Database and Market Summary Report, visit the corporate website at www.imvinfo.com or call 847-297-1404 to speak with a representative.
IMV Medical Information Division is a marketing research and consulting firm founded in 1977, specializing in medical imaging and other advanced healthcare technology markets. IMV's marketing consulting services, in combination with our census databases of U.S. imaging sites with selected modalities, provide clients valuable assistance in strategic planning, customer satisfaction, product development and sales initiatives. Current census databases include interventional angiography, radiographic fluoroscopy, cardiac catheterization, CT, MRI, nuclear medicine, echocardiography, PET, radiation oncology, X-ray/DR/CR and RIS/PACS.
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All